A Cure for Blindness

More than 15 million Americans have some form of age-related macular degeneration (AMD), an eye disease that destroys central vision and leads to blindness and difficulty doing even the simplest daily activities.

To the rescue: a tiny, FDA-approved telescope implant that uses micro-optical technology to fully restore a person's vision.

Dr. Julia A. Haller, ophthalmologist-in-chief at the Wills Eye Hospital in Philadelphia, talks about this groundbreaking device and procedure. Find out how this smaller-than-a-pea technology can help reverse blindness, allowing people to read, see faces and enjoy more independent lives.

Bonus!

RealAge Tip
8 Natural Energy Boosters
A Cure for Blindness
Featuring:
Julia A. Haller, MD
Dr. Julia A. Haller is Ophthalmologist-in-Chief of the Wills Eye Hospital in Philadelphia, where she holds the William Tasman, M.D. Endowed Chair. She serves as Professor and Chair of the Department of Ophthalmology at Jefferson Medical College of Thomas Jefferson University and Thomas Jefferson University Hospitals. She graduated from the Bryn Mawr School, magna cum laude in Philosophy from Princeton University, and from Harvard Medical School.

She completed a surgical internship at Johns Hopkins and a fellowship in ocular pathology with Frederick A. Jakobiec, M.D. at Manhattan Eye, Ear and Throat Hospital, followed by her residency at the Wilmer Eye Institute at Johns Hopkins Hospital. She was a vitreoretinal surgical fellow with Ronald G. Michels, M.D. at Hopkins, and then became Wilmer's first female Chief Resident. Joining the faculty in 1987, she was honored with the inaugural Katharine Graham Professorship in Ophthalmology in 2003, and subsequently the inaugural Robert Bond Welch, M.D. Professorship, and directed the Retina Fellowship program. She assumed leadership of Wills in 2007.